Novavax, Inc. Share Price & Technical Analysis
NVAX · $9.21 (+2.56%)
Healthcare / Biotechnology
$9.21
+2.56%
Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Comp…
Price chart
Seasonality
May has 5 positive and 0 negative years (last 5 years shown)
16% return in May, 88% avg return in past 3 year May month.
42% return in 2026, 49% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 31% | 16% | -17% | -4% | 16% | – | – | – | – | – | – | – | 42% |
| 25 | 7% | -1% | -24% | 5% | 9% | -14% | 6% | 17% | 18% | -3% | -15% | -3% | 2% |
| 24 | -17% | 20% | -6% | -10% | 249% | -15% | 1% | 2% | 2% | -24% | -10% | -9% | 183% |
| 23 | 3% | -13% | 1% | 10% | 5% | -7% | 24% | -12% | -10% | -7% | -18% | -13% | -37% |
| 22 | -35% | -14% | -7% | -38% | 23% | -8% | 5% | -39% | -45% | 21% | -28% | -37% | -202% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Strong · Uptrend
Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$1.60B
P/E ratio
—
52W high
$11.97
52W low
$6.13
Volume
44,34,612
Beta
2.37
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Novavax, Inc. share price today?
- Novavax, Inc. (NVAX) last traded around $9.21 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does NVAX have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for NVAX. Download the app for real-time alerts.
- How can I analyze Novavax, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.